---
id: 183
title: Infections in Solid Organ Transplant by Timeline
category: special_populations
subcategory: transplant
tags: [SOT, transplant, timeline, CMV, BK-virus, *Nocardia*, PCP, prophylaxis]
difficulty: high
---

## Question

What infections occur by post-transplant timeline? Use **"<1mo: Surgical/Nosocomial, 1-6mo: Opportunistic (CMV, PCP, *Nocardia*), >6mo: Community"** framework.

## Answer

### **<1 Month (Early Post-Transplant):**

**Surgical/Nosocomial:**
- **Surgical site infections** (wound, intra-abdominal abscess)
- **Catheter-related bloodstream infections** (central lines)
- **UTIs** (Foley catheters)
- **Hospital-acquired pneumonia**
- **Donor-derived infections** (rare - HIV, HCV, HBV, rabies, *Toxoplasma*, *Strongyloides*, TB, fungi)
- ***Clostridioides difficile* colitis**

**Organisms:** *S. aureus*, *E. coli*, *Klebsiella*, *Pseudomonas*, *Candida*

### **1-6 Months (Peak Immunosuppression, Opportunistic Infections):**

**Viral:**
- **CMV** (most common) - pneumonitis, colitis, hepatitis, retinitis
- **EBV** - post-transplant lymphoproliferative disorder (PTLD)
- **BK polyomavirus** (kidney transplant) - nephropathy
- **HSV, VZV** (if no prophylaxis)

**Bacterial:**
- ***Nocardia* species** - pulmonary, CNS (brain abscess)
- ***Listeria monocytogenes*** - meningitis, bacteremia
- **Legionella** - pneumonia

**Fungal:**
- ***Pneumocystis jirovecii*** (if no prophylaxis)
- ***Aspergillus*** (lung/liver transplant higher risk)
- **Endemic fungi** (*Histoplasma*, *Coccidioides*, *Blastomyces*) - if from endemic area
- ***Cryptococcus***

**Parasitic:**
- ***Toxoplasma gondii*** (heart transplant, donor-derived)
- ***Strongyloides* hyperinfection** (if from endemic area, not on prophylaxis)

### **>6 Months (Late Post-Transplant):**

**If Good Graft Function, Low Immunosuppression:**
- **Community-acquired infections** (similar to general population)
- **Influenza, COVID-19, pneumococcal pneumonia, UTIs**

**If Chronic Rejection, High Immunosuppression:**
- **Opportunistic infections** (CMV, *Aspergillus*, *Cryptococcus*, *Nocardia*, PCP)
- **Progressive multifocal leukoencephalopathy (PML)** - JC virus

### **Prophylaxis Strategies:**

**CMV:**
- **High-risk (D+/R-):** Valganciclovir 900mg PO daily × 3-6 months (duration varies by organ)
- **Moderate-risk (R+):** Valganciclovir × 3 months OR preemptive therapy (monitor CMV PCR, treat if positive)

**PCP:**
- **TMP-SMX DS daily** or **SS daily** × ≥6-12 months (some continue lifelong)
- Alternative: Dapsone, atovaquone, pentamidine inhaled

***Toxoplasma* (Heart Transplant):**
- **TMP-SMX** (also covers PCP)
- **If D+/R-:** Continue × 6-12 months

**Antifungal (High-Risk):**
- **Lung transplant:** Voriconazole, itraconazole, or amphotericin (first 3-4 months)
- **Liver transplant (selected):** Fluconazole, micafungin

**Antivirals:**
- **Acyclovir/valacyclovir** × 3-12 months (HSV, VZV prophylaxis)

## Key Points

### **CMV = #1 Opportunistic Infection:**
- **Peak 1-6 months** post-transplant
- **D+/R- highest risk** (seronegative recipient, seropositive donor)
- **Prophylaxis:** Valganciclovir × 3-6 months (high-risk)

### ***Nocardia* = Pulmonary + CNS:**
- **1-6 months post-transplant** (can occur later)
- **Always image brain** (30-40% have CNS involvement)
- **TMP-SMX prophylaxis** (for PCP) provides *Nocardia* coverage

### **BK Virus (Kidney Transplant):**
- **Nephropathy** (rising creatinine, mimics rejection)
- **Screen plasma BK PCR** monthly × 1st year
- **Treatment:** Reduce immunosuppression

### **PTLD (EBV-Driven):**
- **B-cell lymphoproliferative disorder**
- **Peak 1-6 months** (can occur later)
- **Treatment:** Reduce IS, rituximab, chemotherapy

### **Clinical Pearls:**
- **<1 month:** Surgical/nosocomial (surgical site, catheter, HAP)
- **1-6 months:** Opportunistic (CMV, PCP, *Nocardia*, *Aspergillus*)
- **>6 months:** Community (if good graft function) OR opportunistic (if chronic rejection)
- **Prophylaxis:** Valganciclovir (CMV), TMP-SMX (PCP + *Nocardia* + *Toxoplasma*), valacyclovir (HSV/VZV)
- ***Nocardia*:** ALWAYS image brain (30-40% CNS involvement)

## Sources

- [AST: Infection in SOT Guidelines 2024]
- [Transplant ID: Opportunistic Infections 2024]

## Media

N/A
